As of November 6, 2026, HeartBeam, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on June 24, 2026, naming 1 departure. The latest filing names Mark Strome, leaving (Form 8-K, June 24, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like HeartBeam, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
HeartBeam, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-06-24. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as HeartBeam, Inc. files it.
Also on the record for HeartBeam, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 13, 2026 | Stake report, Schedule 13D/A, by STROME MARK E | 6.8% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs HeartBeam, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on HeartBeam, Inc. and the records around it.
HeartBeam, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- STROME MARK E also filed stake reports on 2 other companies: Cue Biopharma, Inc. (Oct 2026), Zivo Bioscience (Feb 2026)
Watch HeartBeam, Inc.
Get an email when HeartBeam, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on HeartBeam, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on HeartBeam, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on HeartBeam, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
2 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-06-24 | Out | 8-K, 2026-06-24 |
New leaders reset buying decisions — get the Full Report on HeartBeam, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at HeartBeam, Inc., with the record behind each one.
Find candidates like senior executive at HeartBeam, Inc.Every change, in the filing's words
Departing: Mark Strome
Mark Strome Resignation On June 18, 2026, Mark Strome notified the Company of his resignation from the Board and all committees thereof, effective immediately.
- Robert P. Eno Departure On June 18, 2026, Heartbeam, Inc. (the "Company") and Mr. Eno mutually agreed to his departure as the Company's Chief Executive Officer, as a member of the Company's Board of Directors (the "Board"), and as the Company's principal executive officer, effective as of June 30, 2026, in connection with a strategic reorganization within the Company.
- Mr. Eno's decision to depart is not the result of any dispute or disagreement with the Company on any matter relating to the Company's operations, policies or practices.
- In connection with Mr. Eno's departure, it is expected that he and the Company will enter into a consulting agreement whereby Mr. Eno is expected to provide support services to the Company following June 30, 2026, in an advisory capacity.
- Any payment of the severance amounts pursuant to the terms of Mr. Eno's Employment Agreement dated as of January 17, 2023 (the "Employment Agreement") is subject to Mr. Eno's execution of a release of claims satisfactory to the Company.
- Until a new Chief Executive Officer is identified, the Company will strategically align its operations around focused implementation teams led by Branislav Vajdic, Ph.D., Founder and President, and Rich Ferrari, Executive Chairman of the Board.
- Dr. Vajdic, will also serve as the Company's principal executive officer, effective July 1, 2026.
Tools for this story
Each opens in a new tab, filled in for HeartBeam, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.